Screening and Diagnosis | Personalized Treatment | Research and Clinical Trials | Additional Patient Support
Testicular cancer occurs in the testicles (testes). Testicular cancer is rare and strikes mostly young men between the ages of 15 and 34.
The experienced, collaborative team of specialists at NorthShore Kellogg Cancer Center combines the most advanced scientific knowledge and technology with a comprehensive and compassionate approach to care, creating a program of personalized medicine and patient-centered care for each individual diagnosed with testicular cancer.
Drawing from the diverse experience of physicians, surgeons, nurses, researchers and a host of other highly trained healthcare professionals, the Kellogg Cancer Center team works collaboratively and is dedicated to putting patients—and families—at the center of a healthcare experience that delivers compassionate, quality care.
Patients who are newly diagnosed with testicular cancer have the added support of a specialized oncology nurse navigator to guide them through their diagnosis and treatment.
As part of the Mayo Clinic Care Network, NorthShore provides our patients even greater access to a broad network of experts. NorthShore and Mayo specialists share expertise and collaborate to manage complex disease diagnoses and treatments. Patients benefit from enhanced care at NorthShore, without the need to travel outside the region.
Testicular Cancer Screening and Diagnosis
Some men may discover a lump in their testicle even before a physical exam by a doctor. When having a testicular cancer screening, your doctor will perform a physical exam and order further testing, including blood tests to measure certain tumor markers and ultrasound to see a picture of the mass in a patient’s testicle.
To make a definitive diagnosis of testicular cancer, a biopsy will be performed. This involves removal of tissue to be examined by a pathologist. NorthShore's expert pathology department ensures that a majority of tests and novel diagnostics are completed in house, providing swift results and thus beginning testicular cancer treatment as early as possible.
If a diagnosis of testicular cancer is made, a physician will determine the severity or stage of the cancer, including whether it has spread to other areas of the body.
Personalized Testicular Cancer Treatment
Testicular cancer is highly treatable and type of treatment will be recommended based on the stage of cancer. Multimodal strategies combining chemotherapy, radiation therapy and surgery are often used to ensure the best possible outcomes. We also offer a program of active surveillance following surgery in which patients are monitored regularly and only treated with another form of testicular cancer treatment (chemotherapy, radiation or both) if active cancer recurs. Because testicular cancer affects mostly young men of childbearing age, helping patients maintain fertility is of high importance.
Every week, our multidisciplinary team meets in a multidisciplinary conference to discuss each patient’s case in detail and to design a personalized testicular cancer treatment plan. For testicular cancer, your team may include your medical oncologist, surgeon, radiation oncologist, geneticist, pathologist, nutritionist, pharmacist, interventional radiologist, social worker and researchers, all focused on you. This "meeting of the minds" provides critical input, resulting in an individualized care plan outlining the best course of action for each patient.
Patients are at the center of this multidisciplinary team, and Kellogg staff arrange for them to be seen by their multidisciplinary specialists at one appointment, not only for their convenience but to provide a consensus on their course of treatment. Our use of one of the most advanced Electronic Medical Record (EMR) systems in the country enhances our open communication and promotes collaboration in our patient care.
Research and Clinical Trials
For patients diagnosed with urologic cancers, a vital research enterprise allows Kellogg patients access to the latest drugs and treatment options, as well as a wide array of clinical trials, both at NorthShore and through the University of Chicago, where more than 800 of our attending physicians hold academic appointments. NorthShore's team of testicular cancer experts are active participants and leaders in regional and national research, academic and advocacy organizations.
NorthShore’s nationally recognized Electronic Medical Record (EMR) system offers a data warehouse that enables physicians and researchers to integrate molecular and genomics data with clinical data to determine a patient’s best course of treatment. This information—specific to each patient—helps create an individually tailored treatment plan based on the patient’s genetic makeup and type of cancer. This analysis, through our Center for Biomedical Research Informatics, is yielding new insights into complex diseases and identifying opportunities to improve patient outcomes, as well as addressing the risk factors in individual and family medical histories. Harnessing the power of NorthShore's EMR allows physician-scientists to apply sophisticated analysis to patient records, evaluating outcomes from cases of testicular cancer and using that information to determine the most favorable treatment options for each patient.
NorthShore is the first in the nation to provide our patients and their family members with Health Heritage, a secure tool that helps individuals create a complete family health history and personalized risk reports.
Additional Patient Support
Kellogg Cancer Center’s unique services and resources assist patients and family members with a variety of challenges they may face from diagnosis, treatment and beyond. A wide array of support services are available to patients that include our integrative medicine services, financial advocacy and survivorship, to name a few.
For More Information
For more information or to schedule an appointment with one of our specialists, please call 847.570.2112.